Clinical Trial Update: Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate [Phase 4]

View source ↗

Summary

Phase 4 trial assessing induction strategies with low tacrolimus exposure in kidney transplant patients treated with everolimus or mycophenolate to evaluate eff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Renal Transplant Failure
• Transplant Rejection

Drugs mentioned

• Everolimus (everolimus)
• Mycophenolate sodium (mycophenolate sodium)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Hospital do Rim e Hipertensão | Conditions: Cytomegalovirus Infection, Renal Transplant Failure | Phase 4 | Status: COMPLETED